Unknown

Dataset Information

0

Pharmacogenetics of steroid-responsive acute graft-versus-host disease.


ABSTRACT: Glucocorticoids are central to effective therapy of acute graft-versus-host disease (GVHD). However, only about half of the patients respond to steroids in initial therapy. Based on postulated mechanisms for anti-inflammatory effectiveness, we explored genetic variations in glucocorticoid receptor, co-chaperone proteins, membrane transporters, inflammatory mediators, and variants in the T-cell receptor complex in hematopoietic cell transplant recipients with acute GVHD requiring treatment with steroids and their donors toward response at day 28 after initiation of therapy. A total of 300 recipient and donor samples were analyzed. Twenty-three SNPs in 17 genes affecting glucocorticoid pathways were included in the analysis. In multiple regression analysis, donor SNP rs3192177 in the ZAP70 gene (O.R. 2.8, 95% CI: 1.3-6.0, P=.008) and donor SNP rs34471628 in the DUSPI gene (O.R. 0.3, 95% CI: 0.1-1.0, P=.048) were significantly associated with complete or partial response. However, after adjustment for multiple testing, these SNPs did not remain statistically significant. Our results, on this small, exploratory, hypothesis generating analysis suggest that common genetic variation in glucocorticoid pathways may help identify subjects with differential response to glucocorticoids. This needs further assessment in larger datasets and if validated could help identify subjects for alternative treatments and design targeted treatments to overcome steroid resistance.

SUBMITTER: Arora M 

PROVIDER: S-EPMC5413396 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacogenetics of steroid-responsive acute graft-versus-host disease.

Arora Mukta M   Weisdorf Daniel J DJ   Shanley Ryan M RM   Thyagarajan Bharat B  

Clinical transplantation 20170404 5


Glucocorticoids are central to effective therapy of acute graft-versus-host disease (GVHD). However, only about half of the patients respond to steroids in initial therapy. Based on postulated mechanisms for anti-inflammatory effectiveness, we explored genetic variations in glucocorticoid receptor, co-chaperone proteins, membrane transporters, inflammatory mediators, and variants in the T-cell receptor complex in hematopoietic cell transplant recipients with acute GVHD requiring treatment with s  ...[more]

Similar Datasets

2023-12-19 | PXD012036 | Pride
| S-EPMC7705269 | biostudies-literature
| S-EPMC7192843 | biostudies-literature
| S-EPMC9209553 | biostudies-literature
| S-EPMC6861661 | biostudies-literature
| S-EPMC7101733 | biostudies-literature
| S-EPMC6102256 | biostudies-other
| S-EPMC1895490 | biostudies-literature
| S-EPMC7011641 | biostudies-literature
| S-EPMC8360209 | biostudies-literature